$CTSH

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

Original reporting
Published Jul 29, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 6:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$CTSHNeutralMed
01

Why it matters

Traders can update near-term expectations using the revised constant-currency revenue guidance (4% to 5.5%), margin guidance (16% to 16.2%), and working-capital and financing headwinds (DSO up, interest expense higher).

02

Market read

Fresh forward guidance ranges and explicit operating drivers (Q4 ramp, deal conversion, margin support, DSO and interest expense) make this a usable input for earnings-model and positioning decisions.

03

What to watch

DSO rose to 88 days and interest expense increased after a $1B revolver draw for Astreya plus aggressive buybacks, which could pressure free cash flow even if operating margin holds.

Relevance 8/10Novelty 7/10Timing: after-hours following the Q2 2026 earnings call summary

Background

The article summarizes Cognizant’s Q2 2026 earnings call, emphasizing its transition to an AI delivery model, Project LEAP efficiencies, and the Astreya acquisition.

Company-level read

Ticker impact

$CTSHNeutralMedium confidence
Context

Cognizant revised full-year revenue guidance to 4% to 5.5% constant-currency growth and reiterated 16% to 16.2% adjusted operating margin.

Expected impact

Moderate upside bias if investors believe the Q4 ramp and deal-to-bill conversion assumptions hold; otherwise downside risk from cautious discretionary spending.

Evidence & confidence

The article provides specific forward guidance ranges, margin support drivers, and working-capital and interest-expense headwinds, which are directly usable for valuation and scenario modeling.

Market effects

Reinforces the IT services shift toward AI-assisted development, outcome-based pricing, and agentic BPO, which can influence read-across expectations for peers’ margins and deal conversion.

North America deal execution is highlighted as the growth driver, suggesting regional demand resilience for large IT services contracts.

AI infrastructure buildout demand is cited via the Astreya acquisition, aligning with broader global capex themes for data centers and digital workplaces.

Counterpoint

The guidance assumes a superior Q4 ramp and lower year-end furlough proportion; if bookings do not convert to billable volumes, the revenue trajectory could miss despite margin support.

Key entities

  • Cognizant Technology Solutions Corporation

    Subject of the earnings call summary, providing revised full-year guidance and strategic updates on AI delivery and Project LEAP.

  • Astreya

    Acquired to strengthen data center infrastructure and digital workplace capabilities, funded partly via a $1B revolver draw.

  • Project LEAP

    Operational efficiency initiative cited as supporting adjusted operating margin guidance and delivering full-year benefits in 2027.

Related articles

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.

$CTSHMedAI 8/10

Cognizant Reports Second Quarter 2026 Results

Cognizant (Nasdaq: CTSH) reported Q2 2026 revenue of $5.5B, up 4.5% year over year, and GAAP EPS of $1.36. Adjusted EPS was $1.37. Trailing-12-month bookings rose to $29.1B. The company revised 2026 constant-currency revenue growth guidance to 4.0% to 5.5% and raised adjusted diluted EPS to $5.70 to $5.82, while keeping adjusted operating margin at 16.0% to 16.2%.